Nanodropper Device for Glaucoma

Recruiting in Palo Alto (17 mi)

Overseen byJulius Oatts, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of California, San Francisco

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial is testing if a device called the Nanodropper, which gives smaller eye drops, works as well as regular eye drops for adults with stable glaucoma or high eye pressure. The goal is to see if using less liquid can still effectively lower eye pressure.

Eligibility Criteria

This trial is for adults with stable open-angle glaucoma or ocular hypertension who've been using prostaglandin analogue eye drops. It's not suitable for those who've had recent eye surgery, have uncontrolled glaucoma, acute angle-closure glaucoma, other retinal diseases, or use non-PGA IOP-lowering meds.

Inclusion Criteria

I have been diagnosed with open-angle glaucoma or high eye pressure.

My eye condition has been stable for the last 6 months.

I am using prostaglandin eye drops.

+1 more

Exclusion Criteria

My glaucoma is not under control.

I am using eye pressure medication that is not in the PGA class.

I have had eye surgery or laser procedures in the last 6 months.

+1 more

Participant Groups

The study tests the Nanodropper device to see if it's as good as standard eye drops at lowering intraocular pressure in patients with glaucoma. The goal is to prove that smaller drops from this device work just as well without compromising treatment efficacy.

2Treatment groups

Experimental Treatment

Active Control

Group I: NanodropperExperimental Treatment1 Intervention

Participants will receive the Nanodropper with instructions and attend clinic visits at baseline, 1, and 3 months. Participants will administer their eye drops using the Nanodropper.

Group II: Standard of Care DropperActive Control1 Intervention

Participants will receive standard of care eye dropper with instructions and attend clinic visits at baseline, 1, and 3 months. Participants will administer their eye drops using the standard of care eye dropper.